Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Franz Thomas Walt Insider Profile
4 Followers
Franz Thomas Walt, Director at Epigenomics, holds 19.50K shares in Epigenomics (Ticker: GB:0QXH). Most recently, Franz Thomas Walt Bought €4,500 shares of Epigenomics on Nov 12, 2019 for an estimated value of 5.00K.
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-46.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Franz Thomas Walt's holdings
Insider Roles
Director
Roles that Franz Thomas Walt holds in companies
Most Profitable Insider Trade
The most profitable trade made by Franz Thomas Walt
Franz Thomas Walt's Trading History
List of latest transactions for each holding click on a transaction to see Franz Thomas Walt's performance on stock
You May Also Like
Franz Thomas Walt insider profile FAQ
What is the percentage of profitable transactions made by Franz Thomas Walt?
The percentage of profitable transactions made by Franz Thomas Walt is 0%.
What is the average return per transaction made by Franz Thomas Walt?
The average return per transaction made by Franz Thomas Walt is -46.00%.
What stocks does Franz Thomas Walt hold?
Franz Thomas Walt holds: GB:0QXH stocks.
What was Franz Thomas Walt’s latest transaction?
Franz Thomas Walt latest transaction was an Informative Buy of €5.00K.
What was Franz Thomas Walt's most profitable transaction?
Franz Thomas Walt’s most profitable transaction was an Informative Buy of GB:0QXH stock on May 23, 2019. The return on the trade was -38.00%.
What is Franz Thomas Walt's role in Epigenomics?
Franz Thomas Walt's role in Epigenomics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.